Why is a mouse result not proof for people?

The short answer

Because a mouse is a different animal in a very different setting. Roughly nine in ten drug candidates that look promising in animals fail in human trials.

The short read

Species differ in receptors, metabolism and lifespan.
Animal studies are often small and not blinded.
A result is a reason to test in people, not a result in people.

Mice share most genes with us, but not the details that matter for a drug: how fast it is cleared, which receptors it hits, which tissues it reaches. Lab mice are also inbred, young and kept in uniform conditions. The pattern in drug development is blunt: most candidates that work in animals do not end up approved for people.

The full explanation

Headlines love a mouse. The sentence is nearly always some form of "reverses", "heals" or "boosts". Here is why that is only the first step.

What is different

Receptors. A peptide that fits a mouse receptor may fit the human version less well, or hit extra targets.
Metabolism. Mice process drugs much faster, and a dose in mg per kilogram does not translate by simple multiplication. Researchers use scaling rules that are rough guides, not guarantees.
Life span and disease. A disease induced in a young lab animal on purpose is not the same as a disease that develops over decades.
Environment. Lab mice are genetically uniform, fed the same diet and housed alike. People are not.

What goes wrong in the studies

Animal experiments are often small. Many do not state whether animals were randomly assigned, or whether the person measuring knew which group was which. Both lapses can inflate effects. Negative results are also published less often, so the visible record looks better than the whole record.

The base rate

Across drug development, only about one in ten candidates that enter human trials reaches approval. Most failures are for lack of effect or safety problems that animals did not predict. That figure covers candidates that were already good enough to try in people.

How to read the headline

Check for four things: what animal, how many, what dose and for how long, and whether the finding has been repeated by another lab. Then check whether any human data exists. A mouse result is a good reason to run the next experiment. It is not a reason to expect the same in people.

Jargon? Say it simply

Education only. Not medical advice, no dosing, no product recommendations. Read this first.

Keep going

Related questions

Q13Read the Label

How to Read a BPC 157 Dosage Protocol Page Like a Label

There is no established BPC 157 dose, so a protocol page is not a label. Read it for identity, purity, dose source and approved use, and treat every missing field as the answer.

A real label names the maker, lot, strength, approved use and the trial behind the dose.
Protocol pages usually cite no human trial, only rodent work or nothing at all.
A vial size is the contents of the glass, not a dose.

A vendor protocol page borrows the look of a drug label without the legal duties behind it. It rarely shows a verified identity, a batch linked test, a trial for the dose or an approved use. Anti-doping guidance says no human trial has established efficacy or a safe dose, and in July 2026 an FDA panel vote on compounding was narrow and non-binding. Reading the missing fields is the useful skill.

Q14Read the Label

Buy Peptides Canada Guide to What Health Canada Allows

In Canada, injectable peptides are generally prescription drugs, and unauthorized ones are illegal. Health Canada says research use only labels change nothing, and a DIN or NPN checked in its databases is the test.

Health Canada's April 9, 2026 advisory says unauthorized peptide injectables are illegal and have not been assessed.
A drug needs a DIN and a licensed natural health product needs an NPN, both checkable online.
Approved peptide drugs such as Wegovy, Saxenda, Mounjaro and Zepbound come with a prescription.

Health Canada treats injectable peptides as prescription drugs and says unauthorized products sold online are illegal, unassessed and often marketed as research use only, which does not change their status. The checks are simple: an eight digit DIN for drugs in the Drug Product Database, an NPN for licensed natural health products. Approved peptide drugs exist, but they come with a label, a licensed pharmacy and a prescription.

Q17Read the Label

Reading a CJC 1295 Ipamorelin Stack Label and Its Missing Dosage Fields

No dose is established for a CJC 1295 and ipamorelin stack. The two molecules have very different half-lives, the ratio in a vial is not printed, and no trial tested them together.

Ipamorelin lasts about two hours in volunteers, long-acting CJC 1295 lasts days.
A stack vial rarely states the ratio, the maker or a lot tied to an independent test.
FDA lists both under safety concerns and a 2006 CJC trial was terminated.

A stack puts two molecules with very different clocks under one name, so no single schedule fits both. A vial size describes the powder in the glass, not a dose, and the ratio between the two ingredients is usually not printed. A registry search shows single ingredient studies only, a CJC phase 2 trial that was terminated in 2006 and no study of the pair. FDA records list serious safety questions for each.